Sepsis & infection

Postintensive Care Frailty of Older Patients With Septic Shock: A Post Hoc Analysis of a Multicenter Randomized Controlled Trial

Crit Care MedPublished Secondary analysis of a randomised controlled trial

Authors' conclusion

Baseline frailty before sepsis, organ dysfunction severity, and corticosteroid therapy independently predict severe postintensive care frailty in older adults with septic shock.

Study context

Population
Adults ≥65 years with septic shock in ICUs in Japan, from an RCT of BP targets339 survived to 90 days
Participants
513 adults
Comparison
Postintensive care frailty categories at 90 days
  • No-to-mild frailtyn = 103
  • Moderate frailtyn = 114
  • Severe frailtyn = 122
Methodological detailspost hoc analysis, multicentre
  • Post hoc analysis
  • Multicentre

Primary result

As reported in the abstract

Factors independently associated with postintensive care frailty (ordinal logistic regression, generalized estimating equation model) · 90 days
Adjusted odds ratio (CI)P value
Higher presepsis CFS scoresper 1-point increase
2.03(1.72–2.40)
P < 0.001
Higher sequential organ failure assessment (SOFA) scoresper 1-point increase
1.16(1.06–1.26)
P < 0.001
Corticosteroid use
1.72(1.14–2.61)
P < 0.001

Per 1-point increase, as printed

Further findings

Subgroup analyses (subgroup)

Corticosteroid use associated with frailty deterioration in patients with baseline frailty (Clinical Frailty Scale (CFS) ≥ 5)
Sequential organ failure assessment (SOFA) scores associated with frailty in patients with tissue hypoperfusion (lactate ≥ 2 mmol/L)

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Postintensive Care Frailty of Older Patients With Septic Shock: A Post Hoc Analysis of a Multicenter Randomized Controlled Trial. Crit Care Med. Published 12 August 2026. doi:10.1097/ccm.0000000000007304

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.